Achieving a global consensus on the definitions of skin quality features such as dullness, roughness, and laxity will enhance patient communication and help guide treatment recommendations. Sherket B. Peterson, PhD, Skin Quality Program Director, Clinical Development & Scientific Innovation, Aesthetics Medicine at Allergan Aesthetics, an AbbVie Company, discusses the motivation behind this emerging lexicon and shares some key definitions. This research was presented at the 2025 Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monte Carlo, Monaco.
